Symbols / RGLS
RGLS Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-07 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- Novartis Pays 274% Premium in $1.7B Regulus Therapeutics Acquisition for ADPKD Drug - Stock Titan Wed, 30 Apr 2025 07
- Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates - PR Newswire hu, 08 May 2025 07
- Is Regulus Therapeutics Inc. (RGLS) the Best Rising Penny Stock to Buy According to Analysts? - Yahoo Finance Fri, 18 Apr 2025 07
- Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal - Reuters Wed, 30 Apr 2025 07
- Novartis completes acquisition of Regulus Therapeutics and initiates Nasdaq delisting - Investing.com Wed, 25 Jun 2025 07
- Regulus Therapeutics: An Undervalued Buy, With A $0.90 CVR And A $7 Payout (NASDAQ:RGLS) - Seeking Alpha Wed, 04 Jun 2025 07
- Regulus Therapeutics (RGLS): A Promising Penny Stock for 2025 - GuruFocus Mon, 28 Apr 2025 07
- Regulus Therapeutics Stock Jumps: What’s Next? - StocksToTrade Wed, 30 Apr 2025 07
- Regulus Therapeutics Stock Price Forecast. Should You Buy RGLS? - StockInvest.us ue, 01 Dec 2020 19
- Game-Changing Clinical Data: New Drug Stops Kidney Disease Progression in Phase 1b Trial - Stock Titan hu, 27 Mar 2025 07
- With 64% institutional ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) is a favorite amongst the big guns - Yahoo Finance Sun, 08 Dec 2024 08
- RGLS News Today | Why did Regulus Therapeutics stock go up today? $RGLS - MarketBeat Sat, 23 Jun 2018 01
- Regulus Therapeutics: Poised for Phase 3 Success? - StocksToTrade hu, 27 Mar 2025 07
- RGLS - Regulus Therapeu Latest Stock News & Market Updates - Stock Titan Sat, 08 Aug 2020 05
- Regulus Therapeutics (RGLS) Stock Price, News & Analysis $RGLS - MarketBeat ue, 16 Jun 2015 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for RGLS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|